Intranasal oxytocin versus placebo for hyperphagia and repetitive behaviors in children with Prader-Willi Syndrome: A randomized controlled pilot trial

Oxytocin and potential benefits for obesity treatment

(2017) Pawel K. Olszewski et al.   Current Opinion in Endocrinology Diabetes and Obesity

Oxytocin’s inhibitory effect on food intake is stronger in obese than normal-weight men

(2016) M Thienel et al.   INTERNATIONAL JOURNAL OF OBESITY

Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome

(2016) Lisa C. Burnett et al.   JOURNAL OF CLINICAL INVESTIGATION

A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome

(2014) Stewart L. Einfeld et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

(2014) S.M. Francis et al.   BRAIN RESEARCH

Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia

(2014) Steven B. Heymsfield et al.   Obesity

The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies

(2013) Raye Z. Litten et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms

(2013) Meghan Miller et al.   Autism Research

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

(2012) Evdokia Anagnostou et al.   Molecular Autism